Insomnia is characterized by severe difficulties in falling asleep and staying asleep. Acute insomnia is the most severe form of insomnia. It last for several days up to about a month and is very short-term. It is also known as adjustment insomnia since it usually is caused by a drastic change in environment or during stressful events. Some common causes for acute insomnia are as follow: Cognitive Behavioral Therapy (CBT) is an effective form of treatment for insomnia. Cognitive behavioral therapy is also effective in treating minor forms of insomnia. It can also be used as additional treatment after medication or alternative therapy. Another way of treating insomnia is through medications and lifestyle changes.
Request Free Sample Copy With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-sample/958
According to a study by University of Laval, 2011, about 40 % of the adult Canadian are experiencing one or more symptoms of insomnia. Further, a latest research reported in Nature, 2017, stated that insomnia increases the risk in women to deliver premature babies by 30%. Increase in incidence of insomnia across the globe will propel the insomnia therapeutics market.
Advent of improved therapy with lesser side effects to drive the insomnia therapeutics market growth globally
Benzodiazepines (BZP) such as temazepam and diazepam are the commonly prescribed medication for insomnia. Though these medications are effective, prolonged use of these drugs may cause cognitive impairment, dependency and addiction. The launch of novel drugs such as Intermezzo (2014), tasimelteon (2014) have created a meteoric growth in G7 countries in the insomnia therapeutics and is expected market over the forecast period.
Intermezzo (2014), are used in small doses and administered under the tongue for faster absorption. Tesimelton approved by FDA in 2014 is the only drug approved by FDA for Non-24-Hour Sleep-Wake Rhythm Disorder and it lacks abuse potential. These products are expected to drive the insomnia therapeutics market over the forecast period.
Growing awareness and number of people seeking treatment for insomnia are expected to further contribute to the growth of the market. On the other hand, the loss of exclusivity of the drugs led the market more genericized, which is offering a competitive environment for new players. For instance, non-benzodiazepines and low dose sedating anti-depressants, still considered as a first line of medication for the insomnia, are facing stiff competition from the generics.
Request PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/958
According to a report by Sleep Research Society, 2012, 20% of the general adult population in Canada and U.S is suffering from insomnia and this number is expected to increase in the near future. Problems such as daytime sleepiness, and fatigue is affecting larger number of population and posing a considerable burden on these regions. All these factors will positively impact growth of the insomnia therapeutics market growth in the future period.
Insomnia therapeutics Market Taxonomy
By Drug Class
- Non benzodiazepines
- Benzodiazepines
- Others
By Distribution Channel
- Retail & Hospital Pharmacies
- Online Pharmacies
Rapid entry of new players to have positive impact on the global insomnia therapeutics market
Increasing entry of new players and new devices for insomnia is expected to foster growth of the market. FDA approved new device CerĆŖve Sleep System for insomnia in 2016 this device is used to reduce latency to stage 1 and stage 2 sleep by keeping the forehead cool. Major players in insomnia therapeutics market are GlaxoSmithKline plc, UCB Group, Otsuka Holdings Co., Ligand Pharmaceuticals Incorporated, Axxonis Pharma AG, Kyowa Hakko Kirin Co. Ltd., National Institute of Neurological Disorders and Stroke, Jazz Pharmaceuticals, Inc. Ltd., Omeros Corporation and Manhattan Pharmaceuticals, Inc.
šš”š«š¢š¬šš¦šš¬ ššš„š šš¬ šš¢šÆš
šš®š² ššØš° šš ššÆšš¢š„ šš¢š¬ššØš®š§š š š«šØš¦ šš-šš% šš¢š„š„ šš-ššš-šššš
Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/958
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5Ā Insomnia therapeuticsĀ Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak:Ā Insomnia therapeuticsĀ Industry Impact
Chapter 2Ā Insomnia therapeuticsĀ Competition by Types, Applications, and Top Regions and Countries
2.1Ā Insomnia therapeuticsĀ (Volume and Value) by Type
2.3Ā Insomnia therapeuticsĀ (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4Ā Insomnia therapeuticsĀ Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North AmericaĀ Insomnia therapeuticsĀ Market Analysis
Chapter 6 East AsiaĀ Insomnia therapeuticsĀ Market Analysis
Chapter 7 EuropeĀ Insomnia therapeuticsĀ Market Analysis
Chapter 8 South AsiaĀ Insomnia therapeuticsĀ Market Analysis
Chapter 9 Southeast AsiaĀ Insomnia therapeuticsĀ Market Analysis
Chapter 10 Middle EastĀ Insomnia therapeuticsĀ Market Analysis
Chapter 11 AfricaĀ Insomnia therapeuticsĀ Market Analysis
Chapter 12 OceaniaĀ Insomnia therapeuticsĀ Market Analysis
Chapter 13 South AmericaĀ Insomnia therapeuticsĀ Market Analysis
Chapter 14 Company Profiles and Key Figures inĀ Insomnia therapeuticsĀ Business
Chapter 15Ā Insomnia therapeuticsĀ Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology
Continuedā¦.
Related Market Intelligence Reports:
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Mr. Shah
Senior Client Partner ā Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com